Individuals with MYBPC3 missense VUS predicted to disrupt subdomain folding (STRUM+) present a high incidence of adverse clinical outcomes, including ventricular arrhythmias, heart failure, all-cause mortality, atrial fibrillation, and stroke, similar to pathogenic MYBPC3 variants [88]. This evidence concerns the gene MYBPC3 and heart failure.